Brief: Vincerx Pharma Announces Termination Of Reverse Merger Term Sheet
Feb 28 (Reuters) - Vincerx Pharma Inc VINC.O: VINCERX PHARMA ANNOUNCES TERMINATION OF REVERSE MERGER TERM SHEET AND EVALUATION OF STRATEGIC ALTERNATIVES VINCERX PHARMA INC - CASH RUNWAY EXPECTED TO EXTEND THROUGH LATE Q2 2025 Source text: ID:nGNX4h9G1w Further company coverage: VINC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign